Surfactant therapy using vibrating-mesh nebulizers in adults with COVID-19-induced ARDS: A case series
Description
Coronavirus adult respiratory distress syndrome, characterized by decreased surfactant due to lysis of type II pneumocytes and hyaline membrane formation, contributes to severe hypoxemia. The administration of surfactant via high-flow nasal cannula
